Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (ORGO) Revenue
Annual & quarterly revenue history · segment & region breakdown
ORGO · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsOrganogenesis Holdings Inc. trailing twelve-month (TTM) revenue is $0.51B, an increase of 16.80% year-over-year from $0.56B in FY2025.
Revenue trend
2025 – 2016 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.56B | +$0.08B | +16.80% |
| 2024-12-31 | $0.48B | +$0.05B | +11.29% |
| 2023-12-31 | $0.43B | -$0.02B | -3.94% |
| 2022-12-31 | $0.45B | -$0.02B | -3.52% |
| 2021-12-31 | $0.47B | +$0.13B | +38.15% |
| 2020-12-31 | $0.34B | +$0.08B | +29.63% |
| 2019-12-31 | $0.26B | +$0.07B | +34.91% |
| 2018-12-31 | $0.19B | +$0.19B | — |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Organogenesis Holdings Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Organogenesis Holdings Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Organogenesis Holdings Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ORGO revenue · 4 questionsORGO's trailing twelve-month (TTM) revenue is $0.51B. That is an increase of 16.80% year-over-year from $0.56B in FY2025.
▸ Source: FMP · Organogenesis Holdings Inc. SEC filings · GAAP · Organogenesis Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026